Cargando…
Lung Injury in COVID-19 Has Pulmonary Edema as an Important Component and Treatment with Furosemide and Negative Fluid Balance (NEGBAL) Decreases Mortality
The SARS-CoV2 promotes dysregulation of Renin–Angiotensin–Aldosterone. The result is excessive retention of water, producing a state of noxious hypervolemia. Consequently, in COVID-19 injury lung is pulmonary edema. Our report is a case–control study, retrospective. We included 116 patients with mod...
Autores principales: | Santos, Jose L. Francisco, Zanardi, Patricio, Alo, Veronica, Dos Santos, Vanina, Bovone, Leonardo, Rodriguez, Marcelo, Magdaleno, Federico, De Langhe, Virginia, Villoldo, Andrea, Martinez Souvielle, Romina, Alconcher, Julieta, Quiros, Diego, Milicchio, Claudio, Garcia Saiz, Eduardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966668/ https://www.ncbi.nlm.nih.gov/pubmed/36836076 http://dx.doi.org/10.3390/jcm12041542 |
Ejemplares similares
-
Pulmonary Edema in COVID-19 Treated with Furosemide and Negative Fluid Balance (NEGBAL): A Different and Promising Approach
por: Santos, Jose L. Francisco, et al.
Publicado: (2021) -
Intravenous furosemide vs nebulized furosemide in patients with pulmonary edema: A randomized controlled trial
por: Barzegari, Hasan, et al.
Publicado: (2021) -
Resolution of Macular Edema after Systemic Treatment with Furosemide
por: Koo, Nam Kyun, et al.
Publicado: (2012) -
Therapy with the Combination of Tolvaptan and Furosemide for Refractory Edema in Nephrotic Syndrome
por: Meena, Jitendra, et al.
Publicado: (2020) -
Use of Oral Furosemide in Hemodialysis
por: Siga, Esteban, et al.
Publicado: (2022)